Neurofibroma (patient information)
For the WikiDoc page for this topic, click here
Neurofibroma (patient information) | |
Histopathologic image of cutanous neurofibroma obtained by biopsy | |
ICD-O: | 9540-9550 |
DiseasesDB | 23371 |
MeSH | D009455 |
Editor-in-Chief: Jinhui Wu, MD
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview of neurofibroma
Neurofibroma is genetic disorders of the nervous system that result in the growth of noncancerous tumors along nerves. Studies suggested that the cause of neurofibroma is related to gene mutations. There are two main forms of neurofibroma: peripheral neurofibromatosis and central neurofibromatosis.
Peripheral neurofibromatosis is common. Usual signs of peripheral neurofibromatosis includes more tan spots on the skin, freckles, lumps on the skin and a variety of bone defects, such as bowing of the legs below the knee. Biopsy is the best way for diagnosis. In some cases, genetic testing of a blood sample is needed to confirm the diagnosis. For treatment, surgery can curative. However, they often grow back.
Central neurofibromatosis is rare. Severity of symptoms varies greatly. It depends on the nerve infiltrated. Acoustic nerve is the most commonly affected. Nervous system examination, hearing tests, computed tomography (CT) and magnetic resonance imaging (MRI) may help the diagnosis. In some cases, genetic testing is done to help confirm the diagnosis. Treatments of central neurofibromatosis include surgery, radiation therapy and chemotherapy.
See also
Where to find medical care for neurofibroma?
Directions to Hospitals Treating neurofibroma